0HF3 Profitability Analysis: Past Growth, Margins, Return on Capital, Free Cash Flow, and more - Amerisourcebergen Corp - Alpha Spread
A

Amerisourcebergen Corp
LSE:0HF3

Watchlist Manager
Amerisourcebergen Corp
LSE:0HF3
Watchlist
Price: 240.71 USD 1.63% Market Closed
Market Cap: 49.9B USD
Have any thoughts about
Amerisourcebergen Corp?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Amerisourcebergen Corp

Revenue
283.8B USD
Cost of Revenue
-274.3B USD
Gross Profit
9.6B USD
Operating Expenses
-6.7B USD
Operating Income
2.9B USD
Other Expenses
-1.1B USD
Net Income
1.9B USD

Margins Comparison
Amerisourcebergen Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Amerisourcebergen Corp
LSE:0HF3
47.4B USD
3%
1%
1%
US
Mckesson Corp
NYSE:MCK
67.6B USD
4%
1%
1%
US
Cencora Inc
NYSE:COR
47.6B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
27.7B USD
3%
1%
0%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
US
Henry Schein Inc
NASDAQ:HSIC
8.8B USD
32%
5%
3%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
52.4B CNY
11%
3%
2%
IT
Amplifon SpA
MIL:AMP
6.2B EUR
25%
13%
7%
CN
Huadong Medicine Co Ltd
SZSE:000963
47.8B CNY
32%
9%
8%
CN
Sinopharm Group Co Ltd
HKEX:1099
52.2B HKD
8%
4%
1%
DE
McKesson Europe AG
XHAM:CLS1
5B EUR
10%
1%
-5%
Country US
Market Cap 47.4B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 67.6B USD
Gross Margin
4%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 47.6B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 27.7B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
0%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Operating Margin
9%
Net Margin
7%
Country US
Market Cap 8.8B USD
Gross Margin
32%
Operating Margin
5%
Net Margin
3%
Country CN
Market Cap 52.4B CNY
Gross Margin
11%
Operating Margin
3%
Net Margin
2%
Country IT
Market Cap 6.2B EUR
Gross Margin
25%
Operating Margin
13%
Net Margin
7%
Country CN
Market Cap 47.8B CNY
Gross Margin
32%
Operating Margin
9%
Net Margin
8%
Country CN
Market Cap 52.2B HKD
Gross Margin
8%
Operating Margin
4%
Net Margin
1%
Country DE
Market Cap 5B EUR
Gross Margin
10%
Operating Margin
1%
Net Margin
-5%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Amerisourcebergen Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Amerisourcebergen Corp
LSE:0HF3
47.4B USD
230%
3%
21%
16%
US
Mckesson Corp
NYSE:MCK
67.6B USD
-176%
4%
26%
19%
US
Cencora Inc
NYSE:COR
47.6B USD
230%
3%
21%
16%
US
Cardinal Health Inc
NYSE:CAH
27.7B USD
-28%
2%
22%
17%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
US
Henry Schein Inc
NASDAQ:HSIC
8.8B USD
10%
4%
9%
6%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
52.4B CNY
6%
2%
10%
5%
IT
Amplifon SpA
MIL:AMP
6.2B EUR
15%
4%
12%
7%
CN
Huadong Medicine Co Ltd
SZSE:000963
47.8B CNY
15%
9%
17%
13%
CN
Sinopharm Group Co Ltd
HKEX:1099
52.2B HKD
12%
2%
16%
8%
DE
McKesson Europe AG
XHAM:CLS1
5B EUR
-42%
-13%
8%
6%
Country US
Market Cap 47.4B USD
ROE
230%
ROA
3%
ROCE
21%
ROIC
16%
Country US
Market Cap 67.6B USD
ROE
-176%
ROA
4%
ROCE
26%
ROIC
19%
Country US
Market Cap 47.6B USD
ROE
230%
ROA
3%
ROCE
21%
ROIC
16%
Country US
Market Cap 27.7B USD
ROE
-28%
ROA
2%
ROCE
22%
ROIC
17%
Country KR
Market Cap 12.2T KRW
ROE
7%
ROA
3%
ROCE
9%
ROIC
5%
Country US
Market Cap 8.8B USD
ROE
10%
ROA
4%
ROCE
9%
ROIC
6%
Country CN
Market Cap 52.4B CNY
ROE
6%
ROA
2%
ROCE
10%
ROIC
5%
Country IT
Market Cap 6.2B EUR
ROE
15%
ROA
4%
ROCE
12%
ROIC
7%
Country CN
Market Cap 47.8B CNY
ROE
15%
ROA
9%
ROCE
17%
ROIC
13%
Country CN
Market Cap 52.2B HKD
ROE
12%
ROA
2%
ROCE
16%
ROIC
8%
Country DE
Market Cap 5B EUR
ROE
-42%
ROA
-13%
ROCE
8%
ROIC
6%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top